Personalized Radiotherapy for Improved Clinical Benefit
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: closed (20 August 2023) | Viewed by 1960
Special Issue Editor
Special Issue Information
Dear Colleagues,
Radiotherapy is a medical procedure forming part of the overall therapeutic strategy discussed at a multidisciplinary panel with an optimal goal of locally curing tumors and protecting, as best as possible, the surrounding normal tissues. The use of personalized treatments is increasing in radiation oncology, including technical aspects, biological biomarkers, new combinations with innovative drugs, new dosimetric approaches, and so on.
In this Special Issue of Cancers, we welcome original research articles or comprehensive review articles focusing on the development of any aspects of personalizing radiotherapy (normal tissues or tumors) biomarkers in relation to radiobiology, new technologies to better target the tumors and protect surrounding healthy tissues, new dosimetric aspects, or any innovations to improve clinical benefit using ionizing radiations. I hope that this collection of studies will further increase our knowledge on personalized radiotherapy and provide powerful tools to fight against cancer.
Prof. Dr. David Azria
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized radiotherapy
- radiobiology
- dosimetric
- clinical benefit
- ionizing radiations